CDER will index electronic labeling
A recent FDA draft guidance says that CDER, rather than industry, will insert the machine readable tags known as "indexing" in Structured Product Labeling for drugs. FDA says consistent indexing from one source is needed so users can automatically search and sort product information more comprehensively. Elements that will be indexed include indication, limitations of and conditions for use and pharmacologic class. FDA will begin phased implementation by indexing products' pharmacologic classes, with other elements to follow...
You may also be interested in...
France plans to begin issuing manufacturing quality certificates so firms can import ordinary cosmetics into China without animal testing under a 2020 draft regulation. The Personal Care Products Council is working to find a comparable solution for US manufacturers.
The calcineurin inhibitor, only the second drug to be approved by the US FDA for lupus nephritis, will be competing against GlaxoSmithKline’s Benlysta.
Federal prosecutors’ latest criminal case alleging fraudulent advertising and sales of vitamins and other nutrients available nonprescription in the US as remedies for infections from the novel coronavirus is against Johnny Stine, owner and operator of North Coast Biologics in Seattle.